Molecularly targeted therapies in cancer: a guide for the nuclear medicine physician
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Molecularly targeted therapies in cancer: a guide for the nuclear medicine physician
Authors
Keywords
targeted therapies, pathway, imaging, cancer
Journal
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
Volume 44, Issue S1, Pages 41-54
Publisher
Springer Nature
Online
2017-04-10
DOI
10.1007/s00259-017-3695-3
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Imaging the DNA damage response with PET and SPECT
- (2017) James C. Knight et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- 89 Zr-Bevacizumab PET: Potential Early Indicator of Everolimus Efficacy in Patients with Metastatic Renal Cell Carcinoma
- (2017) Suzanne C. van Es et al. JOURNAL OF NUCLEAR MEDICINE
- Atezolizumab versus docetaxel in patients with previously treated non-small-cell lung cancer (OAK): a phase 3, open-label, multicentre randomised controlled trial
- (2017) Achim Rittmeyer et al. LANCET
- 64Cu-Labeled Trastuzumab Fab-PEG24-EGF Radioimmunoconjugates Bispecific for HER2 and EGFR: Pharmacokinetics, Biodistribution, and Tumor Imaging by PET in Comparison to Monospecific Agents
- (2017) Luke Yongkyu Kwon et al. MOLECULAR PHARMACEUTICS
- Journal watch: diagnostic nanoparticles
- (2017) Marina Pöttler et al. Nanomedicine
- PET-based Imaging of Chemokine Receptor 2 in Experimental and Disease-related Lung Inflammation
- (2017) Yongjian Liu et al. RADIOLOGY
- PET of Poly (ADP-Ribose) Polymerase Activity in Cancer: Preclinical Assessment and First In-Human Studies
- (2017) Loren S. Michel et al. RADIOLOGY
- SPECT and PET radiopharmaceuticals for molecular imaging of apoptosis: from bench to clinic
- (2017) Xiaobo Wang et al. Oncotarget
- MRI-guided liposomes for targeted tandem chemotherapy and therapeutic response prediction
- (2016) Lili Ren et al. Acta Biomaterialia
- Antibody drug conjugates: lessons from 20 years of clinical experience
- (2016) A. W. Tolcher ANNALS OF ONCOLOGY
- PD-L1 Detection in Tumors Using [64Cu]Atezolizumab with PET
- (2016) Wojciech G. Lesniak et al. BIOCONJUGATE CHEMISTRY
- Cancer immunotherapy: the beginning of the end of cancer?
- (2016) Sofia Farkona et al. BMC Medicine
- ErbB2: From an EGFR Relative to a Central Target for Cancer Therapy
- (2016) Nancy E. Hynes CANCER RESEARCH
- Targeting CDK4/6 in patients with cancer
- (2016) Erika Hamilton et al. CANCER TREATMENT REVIEWS
- Diagnosis, monitoring and management of immune-related adverse drug reactions of anti-PD-1 antibody therapy
- (2016) Thomas K. Eigentler et al. CANCER TREATMENT REVIEWS
- Quantitative Imaging in Cancer Clinical Trials
- (2016) T. E. Yankeelov et al. CLINICAL CANCER RESEARCH
- Comparison of the octadentate bifunctional chelator DFO*-pPhe-NCS and the clinically used hexadentate bifunctional chelator DFO-pPhe-NCS for 89Zr-immuno-PET
- (2016) Danielle J. Vugts et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Angiogenesis inhibitors as therapeutic agents in cancer: Challenges and future directions
- (2016) Zhexuan Lin et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- The discovery of vemurafenib for the treatment of BRAF-mutated metastatic melanoma
- (2016) Alex Kim et al. Expert Opinion on Drug Discovery
- Directly targeting the mitochondrial pathway of apoptosis for cancer therapy using BH3 mimetics - recent successes, current challenges and future promise
- (2016) Kristopher A. Sarosiek et al. FEBS Journal
- TP53 Mutational Spectrum in Endometrioid and Serous Endometrial Cancers
- (2016) Anne M. Schultheis et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY
- Molecular Alterations of TP53 are a Defining Feature of Ovarian High-Grade Serous Carcinoma
- (2016) Russell Vang et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY
- Cell cycle checkpoint in cancer: a therapeutically targetable double-edged sword
- (2016) Roberta Visconti et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Synthesis of a [18F]-labeled ceritinib analogue for positron emission tomography of anaplastic lymphoma kinase, a receptor tyrosine kinase, in lung cancer
- (2016) Sandun Perera et al. JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS
- Preclinical Evaluation of 18F-Labeled Anti-HER2 Nanobody Conjugates for Imaging HER2 Receptor Expression by Immuno-PET
- (2016) G. Vaidyanathan et al. JOURNAL OF NUCLEAR MEDICINE
- Detection of HER2-Positive Metastases in Patients with HER2-Negative Primary Breast Cancer Using 89Zr-Trastuzumab PET/CT
- (2016) G. A. Ulaner et al. JOURNAL OF NUCLEAR MEDICINE
- Differential Receptor Tyrosine Kinase PET Imaging for Therapeutic Guidance
- (2016) E. Wehrenberg-Klee et al. JOURNAL OF NUCLEAR MEDICINE
- Standardized uptake value on 18 F-FDG-PET/CT is a predictor of EGFR T790M mutation status in patients with acquired resistance to EGFR-TKIs
- (2016) Tatsuya Yoshida et al. LUNG CANCER
- Development and preclinical studies of 64Cu-NOTA-pertuzumab F(ab′)2 for imaging changes in tumor HER2 expression associated with response to trastuzumab by PET/CT
- (2016) Karen Lam et al. mAbs
- Therapy Monitoring with Functional and Molecular MR Imaging
- (2016) Roberto García-Figueiras et al. Magnetic Resonance Imaging Clinics of North America
- [89Zr]Trastuzumab: Evaluation of Radiation Dosimetry, Safety, and Optimal Imaging Parameters in Women with HER2-Positive Breast Cancer
- (2016) Richard Laforest et al. MOLECULAR IMAGING AND BIOLOGY
- Erratum: The future of cancer treatment: immunomodulation, CARs and combination immunotherapy
- (2016) Danny N. Khalil et al. Nature Reviews Clinical Oncology
- Imaging biomarker roadmap for cancer studies
- (2016) James P. B. O'Connor et al. Nature Reviews Clinical Oncology
- Targeting BCL2 with Venetoclax in Relapsed Chronic Lymphocytic Leukemia
- (2016) Andrew W. Roberts et al. NEW ENGLAND JOURNAL OF MEDICINE
- 18F-nanobody for PET imaging of HER2 overexpressing tumors
- (2016) Catarina Xavier et al. NUCLEAR MEDICINE AND BIOLOGY
- Two anti-angiogenic TKI-PET tracers, [ 11 C]axitinib and [ 11 C]nintedanib: Radiosynthesis, in vivo metabolism and initial biodistribution studies in rodents
- (2016) Paul Slobbe et al. NUCLEAR MEDICINE AND BIOLOGY
- Correlation between early 18F-FDG PET/CT response to BRAF and MEK inhibition and survival in patients with BRAF-mutant metastatic melanoma
- (2016) Ronald J. Schmitt et al. NUCLEAR MEDICINE COMMUNICATIONS
- Change in 18F-Fluoromisonidazole PET Is an Early Predictor of the Prognosis in the Patients with Recurrent High-Grade Glioma Receiving Bevacizumab Treatment
- (2016) Shigeru Yamaguchi et al. PLoS One
- [18F]CFA as a clinically translatable probe for PET imaging of deoxycytidine kinase activity
- (2016) Woosuk Kim et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Laying a trap to kill cancer cells: PARP inhibitors and their mechanisms of action
- (2016) Y. Pommier et al. Science Translational Medicine
- Next-generation EGFR/HER tyrosine kinase inhibitors for the treatment of patients with non-small-cell lung cancer harboring EGFR mutations: a review of the evidence
- (2016) Xiaochun Wang et al. OncoTargets and Therapy
- Targeting DNA Repair in Cancer: Beyond PARP Inhibitors
- (2016) Jessica S. Brown et al. Cancer Discovery
- In Vitro and In Vivo Evaluation of 89Zr-DS-8273a as a Theranostic for Anti-Death Receptor 5 Therapy
- (2016) Ingrid J.G. Burvenich et al. Theranostics
- Understanding and Targeting MET Signaling in Solid Tumors - Are We There Yet?
- (2016) Witthawat Ariyawutyakorn et al. Journal of Cancer
- Early 18F-FDG uptake as a reliable imaging biomarker of T790M-mediated resistance but not MET amplification in non-small cell lung cancer treated with EGFR tyrosine kinase inhibitors
- (2016) Viviana De Rosa et al. EJNMMI Research
- Therapeutic Targeting of Autophagy
- (2016) Christina G. Towers et al. EBioMedicine
- Molecular imaging as a tool to investigate heterogeneity of advanced HER2-positive breast cancer and to predict patient outcome under trastuzumab emtansine (T-DM1): the ZEPHIR trial
- (2015) G. Gebhart et al. ANNALS OF ONCOLOGY
- Optimized time-resolved imaging of contrast kinetics (TRICKS) in dynamic contrast-enhanced MRI after peptide receptor radionuclide therapy in small animal tumor models
- (2015) Joost Haeck et al. Contrast Media & Molecular Imaging
- Autophagy in malignant transformation and cancer progression
- (2015) L. Galluzzi et al. EMBO JOURNAL
- Molecular imaging of EGFR and CD44v6 for prediction and response monitoring of HSP90 inhibition in an in vivo squamous cell carcinoma model
- (2015) Diana Spiegelberg et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Safety evaluation of olaparib for treating ovarian cancer
- (2015) Stephanie Lheureux et al. Expert Opinion On Drug Safety
- Crizotinib in the management of advanced-stage non-small-cell lung cancer
- (2015) Herbert H Loong et al. Future Oncology
- TP53 hot spot mutations in ovarian cancer: Selective resistance to microtubule stabilizers in vitro and differential survival outcomes from The Cancer Genome Atlas
- (2015) Brandon-Luke L. Seagle et al. GYNECOLOGIC ONCOLOGY
- The PI3K/AKT/mTOR pathway as a therapeutic target in ovarian cancer
- (2015) Seiji Mabuchi et al. GYNECOLOGIC ONCOLOGY
- Lenvatinib, everolimus, and the combination in patients with metastatic renal cell carcinoma: a randomised, phase 2, open-label, multicentre trial
- (2015) Robert J Motzer et al. LANCET ONCOLOGY
- Targeting the DNA Damage Response in Cancer
- (2015) Mark J. O’Connor MOLECULAR CELL
- Recent Advances in the Development and Application of Radiolabeled Kinase Inhibitors for PET Imaging
- (2015) Vadim Bernard-Gauthier et al. MOLECULES
- Autophagy at the crossroads of catabolism and anabolism
- (2015) Jasvinder Kaur et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Palbociclib in Hormone-Receptor–Positive Advanced Breast Cancer
- (2015) Nicholas C. Turner et al. NEW ENGLAND JOURNAL OF MEDICINE
- Neoantigens in cancer immunotherapy
- (2015) T. N. Schumacher et al. SCIENCE
- Targeting Cyclin-Dependent Kinases and Cell Cycle Progression in Human Cancers
- (2015) Loredana Santo et al. SEMINARS IN ONCOLOGY
- Hitting cancers’ weak spots: vulnerabilities imposed by p53 mutation
- (2015) Evrim Gurpinar et al. TRENDS IN CELL BIOLOGY
- 89Zr-cetuximab PET imaging in patients with advanced colorectal cancer
- (2015) Catherina Willemien Menke-van der Houven et al. Oncotarget
- Radioiodinated PARP1 tracers for glioblastoma imaging
- (2015) Beatriz Salinas et al. EJNMMI Research
- Targeting Oncogenic Mutant p53 for Cancer Therapy
- (2015) Alejandro Parrales et al. Frontiers in Oncology
- BRAF vs RAS oncogenes: Are mutations of the same pathway equal? Differential signalling and therapeutic implications
- (2015) Eftychia Oikonomou et al. Oncotarget
- Anti-angiogenic therapy for cancer: current progress, unresolved questions and future directions
- (2014) Naveen S. Vasudev et al. ANGIOGENESIS
- The MAPK pathway across different malignancies: A new perspective
- (2014) Mauricio Burotto et al. CANCER
- Molecular Pathways: Exploiting Tumor-Specific Molecular Defects in DNA Repair Pathways for Precision Cancer Therapy
- (2014) F. Dietlein et al. CLINICAL CANCER RESEARCH
- Monitoring Reversal of MET-Mediated Resistance to EGFR Tyrosine Kinase Inhibitors in Non-Small Cell Lung Cancer Using 3'-Deoxy-3'-[18F]-Fluorothymidine Positron Emission Tomography
- (2014) F. Iommelli et al. CLINICAL CANCER RESEARCH
- 89Zr-trastuzumab and 89Zr-bevacizumab PET to Evaluate the Effect of the HSP90 Inhibitor NVP-AUY922 in Metastatic Breast Cancer Patients
- (2014) S. B. M. Gaykema et al. CLINICAL CANCER RESEARCH
- Association of PD-1, PD-1 Ligands, and Other Features of the Tumor Immune Microenvironment with Response to Anti-PD-1 Therapy
- (2014) J. M. Taube et al. CLINICAL CANCER RESEARCH
- Targeting Tumor Suppressor p53 for Cancer Therapy: Strategies, Challenges and Opportunities
- (2014) Bo Hong et al. CURRENT DRUG TARGETS
- Wild type p53 reactivation: From lab bench to clinic
- (2014) Galina Selivanova FEBS LETTERS
- Role of the MEK inhibitor trametinib in the treatment of metastatic melanoma
- (2014) Judy W King et al. Future Oncology
- Stand Up to Cancer Phase Ib Study of Pan-Phosphoinositide-3-Kinase Inhibitor Buparlisib With Letrozole in Estrogen Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer
- (2014) Ingrid A. Mayer et al. JOURNAL OF CLINICAL ONCOLOGY
- Olaparib maintenance therapy in patients with platinum-sensitive relapsed serous ovarian cancer: a preplanned retrospective analysis of outcomes by BRCA status in a randomised phase 2 trial
- (2014) Jonathan Ledermann et al. LANCET ONCOLOGY
- 18F-FDG and 18F-FLT-PET Imaging for Monitoring Everolimus Effect on Tumor-Growth in Neuroendocrine Tumors: Studies in Human Tumor Xenografts in Mice
- (2014) Camilla Bardram Johnbeck et al. PLoS One
- 18F-FDG Is a Surrogate Marker of Therapy Response and Tumor Recovery after Drug Withdrawal during Treatment with a Dual PI3K/mTOR Inhibitor in a Preclinical Model of Cisplatin-Resistant Ovarian Cancer
- (2014) Stéphanie Lheureux et al. Translational Oncology
- Cancer-specific defects in DNA repair pathways as targets for personalized therapeutic approaches
- (2014) Felix Dietlein et al. TRENDS IN GENETICS
- Targeting PI3K/Akt/mTOR Signaling in Cancer
- (2014) Camillo Porta et al. Frontiers in Oncology
- Beyond bevacizumab: investigating new angiogenesis inhibitors in ovarian cancer
- (2013) Federica Tomao et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Angiogenesis-Related Pathways in the Pathogenesis of Ovarian Cancer
- (2013) Nikos Gavalas et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Examining Changes in [18 F]FDG and [18 F]FLT Uptake in U87-MG Glioma Xenografts as Early Response Biomarkers to Treatment with the Dual mTOR1/2 Inhibitor AZD8055
- (2013) Heather G. Keen et al. MOLECULAR IMAGING AND BIOLOGY
- A rheostat for immune responses: the unique properties of PD-1 and their advantages for clinical application
- (2013) Taku Okazaki et al. NATURE IMMUNOLOGY
- Panitumumab–FOLFOX4 Treatment and RAS Mutations in Colorectal Cancer
- (2013) Jean-Yves Douillard et al. NEW ENGLAND JOURNAL OF MEDICINE
- The ErbB/HER family of protein-tyrosine kinases and cancer
- (2013) Robert Roskoski PHARMACOLOGICAL RESEARCH
- Molecular targets for cancer therapy in the PI3K/AKT/mTOR pathway
- (2013) Jiri Polivka et al. PHARMACOLOGY & THERAPEUTICS
- Up-Regulation of PD-L1, IDO, and Tregs in the Melanoma Tumor Microenvironment Is Driven by CD8+ T Cells
- (2013) S. Spranger et al. Science Translational Medicine
- Selective CDK4/6 inhibition with tumor responses by PD0332991 in patients with mantle cell lymphoma
- (2012) J. P. Leonard et al. BLOOD
- Programmed cell death pathways in cancer: a review of apoptosis, autophagy and programmed necrosis
- (2012) L. Ouyang et al. CELL PROLIFERATION
- Apoptosis Imaging to Monitor Cancer Therapy: The Road to Fast Treatment Evaluation?
- (2012) Marijke De Saint-Hubert et al. CURRENT PHARMACEUTICAL BIOTECHNOLOGY
- Trastuzumab Emtansine for HER2-Positive Advanced Breast Cancer
- (2012) Sunil Verma et al. NEW ENGLAND JOURNAL OF MEDICINE
- Colocalization of Inflammatory Response with B7-H1 Expression in Human Melanocytic Lesions Supports an Adaptive Resistance Mechanism of Immune Escape
- (2012) J. M. Taube et al. Science Translational Medicine
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Functional imaging in predicting response to antineoplastic agents and molecular targeted therapies in lung cancer: A review of existing evidence
- (2011) S. Novello et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Integrated genomic analyses of ovarian carcinoma
- (2011) D. Bell et al. NATURE
- T cell exhaustion
- (2011) E John Wherry NATURE IMMUNOLOGY
- Vascular Endothelial Growth Factor as an Anti-Angiogenic Target for Cancer Therapy
- (2010) Gang Niu et al. CURRENT DRUG TARGETS
- PD-L1 regulates the development, maintenance, and function of induced regulatory T cells
- (2009) Loise M. Francisco et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Monitoring Predominantly Cytostatic Treatment Response with 18F-FDG PET
- (2009) K. B. Contractor et al. JOURNAL OF NUCLEAR MEDICINE
- Molecular imaging of cell death
- (2009) Marijke De Saint-Hubert et al. METHODS
- PD-1 and Its Ligands in Tolerance and Immunity
- (2008) Mary E. Keir et al. Annual Review of Immunology
- Bcl-2 family proteins and cancer
- (2008) K W Yip et al. ONCOGENE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now